Here are relevant reports on : regenerative-medicine-market
-
Regenerative Medicine Market by Product (Stem Cell [Autologous, Allogenic], Immunotherapy, Gene Therapy, Tissue Engineering), Application (Musculoskeletal, Cancer, Dermatology, Wound care, Cardiovascular Diseases, Eye Disorders) & Region - Global Forecast to 2028
The global regenerative medicine market, valued at US$13.5B in 2022, is forecasted to grow at a 25.1% CAGR, reaching US$16.0B by 2023 and US$49.0B by 2028. The growth of this market is characterized by the increasing collaborations and partnerships by major market players, and the emerging applications in new therapeutic areas. Rising focus on personalized medicine and increasing regulatory approvals in regenerative medicine are also predicted to drive the market.
- Published: January 2024
- Price: $ 4950
- TOC Available:
-
In Vitro Lung Model Market by Type (2D, 3D (In-house, Commercial)), Application (Drug Screening, Toxicology, 3D Model Development, Basic Research, Physiologic Research, Stem Cell Research, Regenerative Medicine) - Global Forecasts to 2023
The lung in vitro models market is projected to reach USD 427.4 Million by 2023, at a CAGR of 17.5%. The key factors driving the growth of this market include growing focus on developing alternatives for animal testing models, advancements in Cell Culture technologies, and the development of new 3D in vitro models. The major players in the Lung in vitro models market include Epithelix (Switzerland), MatTek Corporation (US), Lonza (Switzerland), ATCC (US), InSphero (Switzerland), Emulate (US), AlveoliX (Switzerland), Oncotheis (Switzerland), Insphero (Switzerland), TissUse (Switzerland), Mimetas (Netherlands), and CN Bio Innovations (UK).
- Published: April 2018
- Price: $ 11000
- TOC Available:
-
Biobanking Market by Product & Service (Equipment, Consumable, Services, Software), Sample Type (Blood, Tissue, Nucleic Acids, Cell lines), Ownership, Application (Regenerative Medicine, Life Science, Clinical Research), End User - Global Forecast to 2028
The global biobanking market, valued at US$2.6B in 2022, is forecasted to grow at a 11.4% CAGR, reaching US$2.9B by 2023 and US$5.0B by 2028. The new research study consists of an industry trend analysis of the market. The market's growth is driven by increasing investments and funding for biobanks, a focus on genetic testing and precision medicine, the preservation of cord blood stem cells, and favorable funding for regenerative medicine research.
- Published: May 2023
- Price: $ 4950
- TOC Available:
-
Stem Cell Assays Market Size by Type (Viability, Proliferation, Differentiation, Apoptosis), Cell Type (Mesenchymal, iPSCs, HSCs, hESCs), Product & Service (Instrument), Application (Regenerative Medicine, Clinical Research), End User - Global Forecast to 2027
The size of global stem cell assays market in terms of revenue was estimated to be worth USD 1.9 billion in 2022 and is poised to reach USD 4.5 billion by 2027, growing at a CAGR of 17.7% from 2022 to 2027. The research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: June 2022
- Price: $ 4950
- TOC Available:
-
Cell Culture Market by Product (Consumables (Media, Sera, Reagents), Vessels (Roller Bottle, Cell Factory, Flask), Equipment (SU Bioreactor, Storage, Incubators, Filtration)), Application (mAbs, Vaccines, Regenerative Medicine) & Region - Global Forecast to 2029
The global cell culture market, valued at US$27.4 billion in 2023, stood at US$30.9 billion in 2024 and is projected to advance at a resilient CAGR of 13.4% from 2024 to 2029, culminating in a forecasted valuation of US$57.9 billion by the end of the period. Growth of the cell culture market can be attributed to factors such as the increasing focus and adoption of single use technologies like single use bioreactors, which offer advantages over methods.
- Published: March 2024
- Price: $ 4950
- TOC Available:
-
Cell Line Development Market by Product (Equipment, Media and Reagents), Source, type & by Application ( Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) - Analysis & Global Forecast to 2019
The global cell line development market is expected to reach 3.96 billion by 2019 from $2.2 billion in 2014, and is expected to grow at a CAGR of 12.5% from 2014 to 2019. The market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). North America is expected to maintain its leadership position in the market in the coming years.
- Published: September 2014
- Price: $ 4950
- TOC Available:
-
3D Bioprinting Market by Component (3D bioprinters (Microextrusion, Inkjet, Laser), Bioinks, Software, Consumable), Material (Hydrogels, ECM), Application (Research (Regenerative Medicine, 3D cell Culture), Clinical (Skin, Bone)) - Global Forecast to 2029
The global 3D bioprinting market, valued at US$1.2 billion in 2023, stood at US$1.3 billion in 2024 and is projected to advance at a resilient CAGR of 10.8% from 2024 to 2029, culminating in a forecasted valuation of US$2.4 billion by the end of the period. The market growth is fueled by the growing adoption of 3D bioprinting technology in the pharmaceutical and cosmetic industries, technological advancements in 3D bioprinting, and the rising demand for organ transplants.
- Published: May 2024
- Price: $ 4950
- TOC Available:
-
Personalized Medicine Market by Product (Personalized Medicine Testing, Personalized Medicine Therapeutics), Application (Oncology, Neurology, Cardiology) - Global Forecast to 2027
The global personalized medicine market is projected to reach USD ~500 billion by 2027 from USD 300 Billion in 2022, at a CAGR of 11% during the forecast period
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Virtual Care Market by Component (Software & Services, Hardware), Consultation Type (Video, Audio, Messaging), Application (Family Medicine, Internal Medicine, Pediatrics), End User (Hospital & Clinics, Pharmacies) & Region - Global Forecasts to 2030
The global virtual care market size is projected to reach $76.9 billion by 2030 from an estimated $8.4 billion in 2022, at a CAGR of 32.1%. The virtual care market is mainly driven by factors such as the increasing need to expand healthcare access especially in the rural areas, growing number of patient population worldwide, a shortage of physicians, advancements in telecommunications and the increasing adoption of digital healthcare services. However, regulatory disparity and reimbursement issues pertaining to virtual care are expected to restrain the growth of this market to a certain extent in the coming years.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
SNP (Single Nucleotide Polymorphism) Market: Genotyping and Analysis, Future of SNPs in Personalized Medicine (2011-2016)
SNP (Single Nucleotide Polymorphism) genotyping is a measurement of genetic variations. It is the most common type of genetic variation between humans. Specific single base pair mutations are ideal for identifying correlation between genotype and human behavior.
- Published: July 2025
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
